Analyst Expectations for Amgen's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Amgen (NASDAQ:AMGN) received mixed analyst ratings with 1 bullish, 4 somewhat bullish, 1 indifferent, and 3 somewhat bearish. Over the past 3 months, 9 analysts have offered 12-month price targets for Amgen, with an average price target of $248.22, a 1.11% decrease from the previous average price target of $251.00.
July 12, 2023 | 6:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Amgen received mixed analyst ratings in the last quarter, with an average 12-month price target of $248.22, a 1.11% decrease from the previous target.
The mixed analyst ratings indicate uncertainty about Amgen's future performance. The decrease in the average price target suggests that analysts have slightly lowered their expectations for the stock, which could potentially impact investor sentiment and the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100